Fetal Weight Calculator

Reviewed by Hamza Gujjar, Algorithm Architect & Software Developer Last updated: August 17, 2026

Obstetric Ultrasonography, Perinatal Biometry, and Estimated Fetal Weight (EFW)

In maternal-fetal medicine, clinical obstetrics, and high-risk perinatology, assessing fetal growth in utero is a vital clinical protocol for ensuring prenatal health and determining delivery timing. Grounded in mathematical regression modeling of ultrasonic sound wave biometry, the Estimated Fetal Weight (EFW) provides clinicians with an objective metric of fetal development. The Fetal Weight Calculator evaluates multi-parameter ultrasound measurements using validated clinical formulas (Hadlock 2-, 3-, and 4-parameter equations, Shepard formula), plots estimated weight against standard gestational age percentile growth curves (INTERGROWTH-21st and WHO fetal growth standards), screens for Intrauterine Growth Restriction (IUGR / Small for Gestational Age - SGA < 10th percentile), and detects Large for Gestational Age (LGA / Fetal Macrosomia > 4,000g / 4,500g).

Clinical fetal biometry relies on four core sonographic anatomical measurements: (1) Biparietal Diameter (BPD): the transverse distance across the fetal skull from outer to inner bone cortex; (2) Head Circumference (HC): the perimeter of the fetal cranium measured at the level of the thalami and cavum septi pellucidi; (3) Abdominal Circumference (AC): the single most sensitive biometric parameter for fetal soft tissue and glycogen liver storage, measured at the junction of the umbilical vein and portal sinus; and (4) Femur Length (FL): the longitudinal shaft measurement of the fetal thigh bone excluding epiphyses.

Core Fetal Weight Formulas and Ultrasonic Biometric Equations

Ultrasonic Fetal Biometry and Weight Milestones Reference Table

Case Study: 34-Week Fetal Biometric Assessment

Frequently Asked Questions

What is the clinical error margin of ultrasound fetal weight estimation?

Published perinatal studies show that ultrasound estimated fetal weight has an inherent error margin of approximately ±10% to 15%. Fetal weight estimation is most accurate in the early third trimester and becomes slightly less accurate at term due to fetal head engagement and maternal body habitus.

What defines Intrauterine Growth Restriction (IUGR / FGR)?

Intrauterine Growth Restriction (IUGR / Fetal Growth Restriction) is diagnosed when ultrasound estimated fetal weight falls below the 10th percentile for gestational age. Clinicians perform umbilical artery Doppler ultrasound assessments to evaluate placental blood flow resistance and ensure adequate fetal oxygenation.

What is fetal macrosomia?

Fetal Macrosomia is clinically defined as an estimated or birth weight exceeding 4,000 grams (8 lbs 13 oz) or 4,500 grams (9 lbs 15 oz), regardless of gestational age. Common risk factors include maternal gestational diabetes, pre-pregnancy obesity, and excessive gestational weight gain.

Why is Abdominal Circumference (AC) the most critical measurement?

The Abdominal Circumference (AC) directly reflects fetal liver size and subcutaneous abdominal adipose tissue. Because the fetal liver stores glycogen, AC is the first biometric parameter to shrink during placental insufficiency (IUGR) and the first to enlarge during maternal hyperglycemia (macrosomia).

Umbilical Artery Doppler Velocimetry in Fetal Growth Restriction

When obstetric ultrasound biometry detects an estimated fetal weight falling below the 10th percentile for gestational age (diagnosing Intrauterine Growth Restriction - IUGR / Fetal Growth Restriction - FGR), maternal-fetal medicine specialists perform Umbilical Artery Doppler Velocimetry to evaluate placental vascular resistance:

• Systolic/Diastolic (S/D) Ratio and Pulsatility Index (PI): Measures blood flow resistance across the umbilical cord. In a healthy placenta, low-resistance vascular beds ensure continuous forward blood flow to the fetus during both cardiac systole and cardiac diastole.
• Absent End-Diastolic Velocity (AEDV): Severe placental vascular obliteration increases resistance until forward diastolic blood flow ceases completely (AEDV). This signals advanced placental insufficiency and requires intensive fetal monitoring.
• Reversed End-Diastolic Velocity (REDV): Diastolic blood flow reverses direction, flowing backward toward the fetal heart during diastole. REDV indicates severe fetal hypoxia and imminent metabolic acidosis, serving as a critical medical trigger for immediate delivery via emergency Cesarean section.

Constitutional Smallness vs. Pathological Placental Growth Restriction

A crucial clinical distinction in perinatal care is differentiating a Constitutionally Small Fetus (SGA) from Pathological Fetal Growth Restriction (FGR):

A constitutionally small fetus is genetically programmed to be small (due to petite maternal and paternal stature), maintains normal umbilical Doppler waveforms, normal amniotic fluid volume (AFI 8 to 18 cm), and follows a steady, proportional growth trajectory along its lower percentile curve without perinatal compromise. By contrast, true pathological FGR is characterized by asymmetric biometric thinning (Abdominal Circumference falling dramatically while Head Circumference is preserved — the "Brain-Sparing Effect"), oligohydramnios (low amniotic fluid), and abnormal uterine artery Doppler waveforms.

Conclusion: The Clinical Precision of Prenatal Fetal Biometry

The Fetal Weight Calculator provides prospective parents and healthcare professionals with an evidence-based computational framework for evaluating ultrasonic fetal biometric measurements. By integrating validated Hadlock equations, standardizing gestational age percentile curves, and screening for growth restrictions, the calculator supports proactive, compassionate prenatal care from mid-pregnancy through delivery.

Amniotic Fluid Dynamics: Amniotic Fluid Index (AFI) and Deepest Vertical Pocket (DVP)

In comprehensive fetal biophysical profiling, estimated fetal weight is evaluated alongside Amniotic Fluid Volume to assess fetal renal perfusion and placental health:

• Amniotic Fluid Index (AFI): Measured by dividing the maternal abdomen into four quadrants and summing the vertical depth (in cm) of the largest fluid pocket in each quadrant. Normal AFI ranges from 8.0 to 18.0 cm.
• Oligohydramnios (AFI < 5.0 cm or Deepest Vertical Pocket < 2.0 cm): Severely reduced amniotic fluid. Because amniotic fluid is primarily fetal urine in the second and third trimesters, oligohydramnios indicates reduced renal arterial perfusion caused by chronic placental insufficiency or ruptured membranes.
• Polyhydramnios (AFI > 24.0 cm or DVP > 8.0 cm): Excess amniotic fluid. Frequently associated with maternal gestational diabetes (fetal osmotic diuresis caused by hyperglycemia) or fetal gastrointestinal atresia impairing swallowing.

Fetal Macrosomia and Shoulder Dystocia Risk Management

When ultrasonic biometric extrapolation indicates an Estimated Fetal Weight exceeding 4,500 grams (9 lbs 15 oz) in diabetic mothers or 5,000 grams (11 lbs) in non-diabetic mothers, clinical obstetric guidelines (ACOG Practice Bulletin) recommend counseling patients regarding elective scheduled Cesarean delivery.

Delivering a macrosomic infant vaginally carries an elevated risk of Shoulder Dystocia — an obstetric emergency where the anterior fetal shoulder impacts behind the maternal pubic symphysis. High maternal blood sugars cause selective overgrowth of the fetal torso (excessive Abdominal Circumference) relative to the head, increasing the risk of brachial plexus nerve stretching (Erb palsy) during delivery.

Gestational Diabetes Mellitus (GDM) and Asymmetric Fetal Overgrowth

In maternal endocrinology, maternal hyperglycemia caused by Gestational Diabetes Mellitus (GDM) activates the Pedersen Hypothesis of fetal hyperinsulinemia:

Maternal glucose crosses the placenta via facilitated diffusion across glucose transporter proteins (GLUT-1). However, maternal insulin cannot cross the placenta. In response to high fetal blood sugar levels, the fetal pancreas secretes large amounts of endogenous fetal insulin — a potent anabolic growth hormone. Fetal hyperinsulinemia stimulates excessive glycogen storage in the fetal liver and massive fat deposition in the fetal abdomen and subcutaneous tissues, causing Asymmetric Fetal Macrosomia (Abdominal Circumference > 95th percentile with normal Head Circumference). Maintaining tight maternal glycemic control (fasting glucose < 95 mg/dL and 1-hour postprandial < 140 mg/dL) normalizes fetal growth velocity and prevents traumatic delivery complications.

Cerebroplacental Ratio (CPR) and Brain-Sparing Hemodynamics

In modern high-risk perinatal monitoring, fetal distress in late pregnancy is evaluated via the Cerebroplacental Ratio (CPR) — the ratio of the Middle Cerebral Artery (MCA) Pulsatility Index to the Umbilical Artery (UA) Pulsatility Index: CPR = MCA_PI / UA_PI.

In a healthy fetus, the brain has higher vascular resistance than the placenta (CPR > 1.08). When chronic placental insufficiency starves the fetus of oxygen, the fetus compensates by dilating cerebral blood vessels to prioritize blood flow to the vital brain tissue — a neuroprotective reflex known as "Brain Sparing" (causing MCA resistance to drop and CPR to fall < 1.0). An abnormal CPR ratio is a strong clinical predictor of intrapartum fetal distress and emergency Cesarean delivery, even when estimated fetal weight falls within the "normal" 10th to 90th percentile range.

The INTERGROWTH-21st International Fetal Growth Standards

In global prenatal epidemiology and neonatology, the World Health Organization and the University of Oxford established the INTERGROWTH-21st Project — the first truly international, prospective fetal growth standard:

Conducted across eight diverse urban populations worldwide (including the UK, US, Brazil, Kenya, India, Italy, China, and Oman), the study enrolled healthy mothers with optimal nutrition and prenatal care. The clinical findings proved that when environmental, socioeconomic, and nutritional constraints are minimized, human fetuses grow at virtually identical biological rates across all racial and ethnic backgrounds, establishing universal ultrasonic biometric percentiles that eliminate outdated, racially stratified growth curves.

Post-Term Pregnancy Risks and Placental Senescence (Postmaturity Syndrome)

When gestation extends beyond 41 to 42 completed weeks (Post-Term Pregnancy), the placenta begins a biological aging process known as Placental Senescence:

Aged placental syncytiotrophoblast tissue calcifies and undergoes fibrinoid necrosis, causing nutrient and oxygen transfer to deteriorate. The fetus exhausts subcutaneous fat stores and begins metabolizing its own adipose tissue — resulting in Postmaturity Syndrome (dysmaturity), characterized by fetal weight loss, peeling parchment-like skin, oligohydramnios, and increased risk of meconium aspiration. Obstetricians perform serial biophysical profiles and recommend labor induction by 41 weeks to prevent post-term perinatal morbidity.

Common Pitfalls in Ultrasonic Fetal Weight Interpretation

Ensure balanced prenatal expectations and clinical perspective by avoiding these common ultrasound misinterpretations:

• Treating Estimated Fetal Weight as an Absolute Exact Measurement: Ultrasound fetal weight estimation has a standard clinical error margin of ±10% to 15%. A fetus estimated at 3,000 grams could realistically weigh anywhere between 2,550g and 3,450g at delivery.
• Panicking Over a Single Isolated Ultrasound Percentile Drop: Fetal growth occurs in non-linear biological spurts. Rather than reacting to a single data point, maternal-fetal specialists evaluate serial scans spaced at least 2 to 3 weeks apart to assess true velocity.
• Equating Large Fetal Size with Guaranteed Cesarean Delivery: High estimated fetal weight alone is not an automatic indication for Cesarean delivery. Clinical guidelines recommend trial of labor for most large fetuses unless severe macrosomia thresholds are breached.

Prenatal Growth Tracking and Obstetric Ultrasound Best Practices Checklist

Support optimal fetal development and prenatal health with these clinical recommendations:

• Perform Mid-Trimester Anatomy Scan at 18 to 22 Weeks: Establish precise baseline biometric measurements (BPD, HC, AC, FL) and confirm gestational dating.
• Monitor Maternal Glycemic Control Rigorously: Prevent fetal hyperinsulinemia and macrosomia by screening for gestational diabetes between 24 and 28 weeks.
• Evaluate Umbilical Doppler Waveforms in Suspected IUGR: Confirm adequate forward placental diastolic perfusion if estimated weight falls below the 10th percentile.
• Assess Amniotic Fluid Volume (AFI) Alongside Weight: Maintain healthy maternal hydration to ensure normal amniotic fluid index (8 to 18 cm).

Symphysis-Fundal Height (SFH) Clinical Screening in Primary Prenatal Care

In routine obstetric examinations where ultrasound equipment is not used at every visit, midwives and obstetricians monitor fetal somatic growth using Symphysis-Fundal Height (SFH) measurement:

Using a non-elastic measuring tape, the clinician measures the distance from the top of the maternal pubic bone (pubic symphysis) to the uppermost curve of the uterine fundus. Between 20 and 36 weeks of gestation, the fundal height in centimeters should correspond to the gestational age in weeks (± 2 to 3 cm — e.g., a 28-week pregnancy typically measures 26 to 30 cm). A discrepancy greater than 3 cm (fundal height lagging behind or measuring far ahead) triggers an immediate diagnostic ultrasound biometry examination to calculate true Estimated Fetal Weight (EFW) and assess amniotic fluid index.

Third-Trimester Growth Velocity and Serial Ultrasound Intervals

During the third trimester, human fetuses gain weight rapidly, accumulating approximately 200 to 250 grams (7 to 9 oz) per week between Weeks 32 and 38. When monitoring high-risk pregnancies for fetal growth restriction or macrosomia, clinical protocols mandate spacing ultrasound biometry scans at least 14 to 21 days apart. Scanning too frequently (e.g., weekly) introduces measurement noise and calliper variance that can artificially mimic growth arrest or acceleration.

Biophysical Profile (BPP) and Comprehensive Perinatal Monitoring

In high-risk maternal-fetal medicine, Estimated Fetal Weight is combined with the Manning Biophysical Profile (BPP) to assess acute and chronic fetal health across five parameters scored 0 or 2:

• 1. Fetal Breathing Movements: At least one episode of continuous rhythmic breathing ≥ 30 seconds.
• 2. Gross Fetal Body Movements: At least 3 discrete body or limb movements.
• 3. Fetal Tone: Active extension of limbs with return to flexion.
• 4. Amniotic Fluid Volume: At least one vertical pocket of amniotic fluid ≥ 2 cm.
• 5. Non-Stress Test (NST): Reactive fetal heart rate accelerations with fetal movement.

A perfect BPP score of 8/8 or 10/10 confirms normal fetal central nervous system oxygenation and reassuring fetal well-being.

Summary: Evidence-Based Prenatal Biometric Tracking

Accurate ultrasonic fetal weight estimation bridges advanced acoustic physics with compassionate perinatal medicine. By evaluating standardized anatomical parameters, plotting longitudinal percentile trajectories, and interpreting Doppler hemodynamic indices, obstetricians and expectant parents ensure healthy prenatal development and safe delivery outcomes.

Use the Fetal Weight Calculator to track and understand your baby developmental milestones with clinical clarity.

Twin and Multiple Gestation Fetal Growth Curves

In twin and multiple pregnancies, singleton fetal growth charts are replaced with specialized Twin-Specific Ultrasonic Biometric Standards. In monochorionic twin pregnancies, serial ultrasound evaluations screen for Twin-to-Twin Transfusion Syndrome (TTTS) by monitoring inter-twin weight discordance (calculated as: [ EFW_larger − EFW_smaller ] / EFW_larger × 100%). An estimated weight discordance ≥ 20% indicates significant hemodynamic imbalance requiring specialized fetal surgical intervention.

Third-Trimester Fetal Position and Biometric Measurement Accuracy

In late third-trimester obstetric ultrasound, the physical orientation of the fetus — whether cephalic (head down), breech (feet down), or transverse — can influence the acoustic plane of acoustic sound waves. High fetal head engagement in the maternal pelvis can slightly compress cranial calipers, which experienced sonographers account for by adjusting the angle of insonation and verifying abdominal circumference measurements.

Understanding ultrasonic biometry provides peace of mind throughout your pregnancy journey.

Maternal Nutrition and Fetal Growth Support

Supporting healthy fetal somatic growth requires balanced maternal nutrition: consuming adequate dietary protein (75 to 100 grams daily), complex carbohydrates, and essential micronutrients — including prenatal iron, calcium, choline, and docosahexaenoic acid (DHA omega-3 fatty acid for fetal neurodevelopment) — ensures optimal placental perfusion and healthy fetal weight development throughout every trimester.

By combining serial ultrasonic biometric evaluations with clinical prenatal care and maternal nutrition, parents and clinicians ensure healthy, safe developmental outcomes for every baby.

Explore the Fetal Weight Calculator to monitor your baby growth milestones and prepare for a healthy, joyful birth experience.

The Fetal Weight Calculator delivers clear, clinical insight to support prospective parents and obstetric healthcare providers throughout every stage of pregnancy.

Track gestational weight percentiles with complete confidence throughout your prenatal journey.